sellWeak
James F. Dempsey sold $173k of VRAY
Chief Scientific Officer at ViewRay, Inc.. 42,000 shares at an average of $4.13, traded Mar 3, 2023, filed Mar 21, 2023.
Warning score
11Value
$173k
42,000 shares
Holdings after
654,368
-6% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleOfficer
- +11Trade size$173k at market
- 0Share of holdings soldSold 6.0% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001628280-23-008798, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 24, 2022 | FTax withholding Common Stock | -37,681 | $4.30 | $162k | 642,165 | Mar 21, 2023 |
| Mar 1, 2023 | AGrant or award Common Stock | +86,405 | $0.00 | $0 | 728,570 | Mar 21, 2023 |
| Mar 1, 2023 | FTax withholding Common Stock | -19,630 | $4.12 | $81k | 708,940 | Mar 21, 2023 |
| Mar 1, 2023 | FTax withholding Common Stock | -14,872 | $4.12 | $61k | 694,068 | Mar 21, 2023 |
| Mar 2, 2023 | FTax withholding Common Stock | -39,700 | $4.12 | $164k | 654,368 | Mar 21, 2023 |
| Mar 3, 2023 | MOption exercise Common Stock | +42,000 | $0.75 | $32k | 696,368 | Mar 21, 2023 |
| Mar 3, 2023 | SOpen-market sale Common Stock | -42,000 | $4.13 | $173k | 654,368 | Mar 21, 2023 |
| Mar 7, 2023 | MOption exercise Common Stock | +125,000 | $0.75 | $94k | 779,368 | Mar 21, 2023 |
| Mar 1, 2023 | AGrant or award Performance Unitsderivative | +86,405 | $0.00 | $0 | 86,405 | Mar 21, 2023 |
| Mar 3, 2023 | MOption exercise Stock Option (right to buy)derivative | -42,000 | $0.75 | $32k | 292,305 | Mar 21, 2023 |
| Mar 7, 2023 | MOption exercise Stock Option (right to buy)derivative | -125,000 | $0.75 | $94k | 167,305 | Mar 21, 2023 |
Related signals
Other insiders at ViewRay, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 28Weak | VRAYbuy ViewRay, Inc. | Susan C Schnabel director | $117k 25,000 shares | +15% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.